Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term InvestmentsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivables - AccuredShareholder's EquityTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monroe Capital (MRCC) Cash & Equivalents (2020 - 2025)

Monroe Capital's Cash & Equivalents history spans 6 years, with the latest figure at $2.4 million for Q2 2025.

  • For Q2 2025, Cash & Equivalents fell 37.44% year-over-year to $2.4 million; the TTM value through Jun 2025 reached $2.4 million, down 37.44%, while the annual FY2024 figure was $9.0 million, 82.41% up from the prior year.
  • Cash & Equivalents for Q2 2025 was $2.4 million at Monroe Capital, down from $6.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $12.3 million in Q2 2023 and bottomed at $2.4 million in Q2 2025.
  • The 5-year median for Cash & Equivalents is $5.7 million (2022), against an average of $6.0 million.
  • The largest annual shift saw Cash & Equivalents plummeted 89.78% in 2021 before it skyrocketed 107.86% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $2.6 million in 2021, then surged by 107.86% to $5.4 million in 2022, then decreased by 9.03% to $5.0 million in 2023, then soared by 82.41% to $9.0 million in 2024, then crashed by 73.19% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for MRCC's Cash & Equivalents are $2.4 million (Q2 2025), $6.5 million (Q1 2025), and $9.0 million (Q4 2024).